Serum neurofilament is a discriminative biomarker between frontotemporal dementia and psychiatric disorders
Early symptoms of frontotemporal dementia are often confused with symptoms occurring in psychiatric disorders. Reporting their findings in Journal of Neurology, Finnish researchers from the University of Eastern Finland and the University of Oulu show that serum neurofilament levels can be used as a diagnostic tool to differentiate between these conditions. Frontotemporal dementia is the second most common progressive and neurodegenerative memory disorder affecting the working age population. Typically, early symptoms of frontotemporal dementia do not include memory impairment. Instead,